🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 1 día
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
09/05/2000 0,0854 USD
16/02/2000 0,0854 USD
09/11/1999 0,0759 USD
04/08/1999 0,0759 USD
05/05/1999 0,0696 USD
10/02/1999 0,0696 USD
04/11/1998 0,0601 USD
05/08/1998 0,0601 USD
06/05/1998 0,0601 USD
04/02/1998 0,0601 USD
05/11/1997 0,0538 USD
30/07/1997 0,0538 USD
07/05/1997 0,0538 USD
05/02/1997 0,0538 USD
06/11/1996 0,0474 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/11/1978 0,64 0,66 0,64 0,64 +0,00% 4,59% 2.671.258
16/11/1978 0,62 0,64 0,62 0,64 +4,40% 4,40% 4.158.662
15/11/1978 0,61 0,64 0,61 0,62 +1,63% 4,48% 3.779.222
14/11/1978 0,62 0,62 0,60 0,61 -1,60% 3,21% 4.902.365
13/11/1978 0,64 0,64 0,62 0,62 -2,72% 2,72% 7.103.117
10/11/1978 0,64 0,64 0,63 0,64 +0,00% 1,56% 2.691.494
09/11/1978 0,64 0,64 0,64 0,64 +0,00% 1,56% 5.484.173
08/11/1978 0,64 0,64 0,63 0,64 -1,54% 3,07% 5.307.101
07/11/1978 0,64 0,64 0,64 0,64 +0,00% 1,54% 3.283.421
06/11/1978 0,66 0,66 0,64 0,64 -2,96% 2,96% 4.229.491
03/11/1978 0,64 0,66 0,64 0,66 +3,05% 4,59% 4.077.715
02/11/1978 0,67 0,67 0,64 0,64 -4,39% 5,86% 5.585.357
01/11/1978 0,65 0,67 0,65 0,67 +6,22% 3,02% 5.706.778
31/10/1978 0,64 0,65 0,64 0,64 +0,00% 3,10% 4.649.405
30/10/1978 0,62 0,64 0,61 0,64 +2,80% 6,01% 5.843.376
27/10/1978 0,64 0,64 0,62 0,62 -2,72% 4,28% 5.524.646
26/10/1978 0,66 0,66 0,64 0,64 -4,45% 4,45% 6.556.723
25/10/1978 0,65 0,67 0,64 0,66 +1,51% 4,52% 3.450.374
24/10/1978 0,64 0,66 0,64 0,65 +1,52% 3,05% 3.293.539
23/10/1978 0,64 0,64 0,64 0,64 +1,56% 1,56% 3.708.394
20/10/1978 0,64 0,65 0,64 0,64 -1,54% 3,05% 3.506.026
19/10/1978 0,68 0,68 0,64 0,64 -5,43% 5,43% 4.882.128
18/10/1978 0,67 0,68 0,67 0,68 +1,10% 1,10% 4.011.946
17/10/1978 0,68 0,68 0,67 0,67 -1,09% 1,09% 2.989.987
16/10/1978 0,70 0,70 0,68 0,68 -2,82% 2,82% 1.902.259
13/10/1978 0,70 0,71 0,70 0,70 +0,00% 1,41% 2.833.152
12/10/1978 0,71 0,72 0,70 0,70 -1,39% 2,78% 3.060.816
11/10/1978 0,70 0,71 0,68 0,71 +1,41% 4,23% 4.087.834
10/10/1978 0,70 0,70 0,69 0,70 +0,00% 1,41% 3.738.749
09/10/1978 0,69 0,70 0,69 0,70 +1,43% 1,43% 1.887.082